Noninvasive Nasal Drops Kill Brain Tumors?
- This article from Futurity.org details a promising new, non-invasive treatment for glioblastoma, a deadly and aggressive form of brain cancer.
- * Novel Delivery Method: The treatment utilizes "spherical nucleic acids" - nanoscale structures with a gold core and DNA snippets - delivered via nasal drops.
- In essence, this research offers a potentially groundbreaking, non-invasive approach to treating glioblastoma by harnessing the power of the immune system.
Summary of the Article: Nasal Drops Eliminate Brain Tumors in Mice
This article from Futurity.org details a promising new, non-invasive treatment for glioblastoma, a deadly and aggressive form of brain cancer. Researchers at Washington University in St. Louis and Northwestern University have successfully eliminated these tumors in mice using nasal drops containing precisely engineered nanostructures.
Key takeaways:
* Novel Delivery Method: The treatment utilizes “spherical nucleic acids” – nanoscale structures with a gold core and DNA snippets – delivered via nasal drops. This is less invasive than current methods requiring direct tumor injection.
* Boosting Immune Response: Glioblastoma tumors are typically “cold,” meaning they don’t trigger the body’s immune response. this treatment activates the STING pathway, a key immune stimulator, within the brain.
* Successful Results in Mice: The nasal drops effectively treated glioblastoma in mice, boosting their brain’s immune response and eliminating the tumors.
* Potential for Human Request: The researchers believe this approach could redefine cancer immunotherapy for difficult-to-access tumors like glioblastoma, minimizing the need for invasive procedures for patients.
* Collaboration: The research was a collaborative effort between Alexander Stegh’s lab at Washington University and Chad Mirkin’s lab at Northwestern University, leveraging Mirkin’s invention of spherical nucleic acids.
In essence, this research offers a potentially groundbreaking, non-invasive approach to treating glioblastoma by harnessing the power of the immune system.
